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ABSTRACT
Disseminated superficial actinic porokeratosis (DSAP) is a skin condition that consist of multiple annular, 
hyperkeratotic lesions. They are usually distributed bilaterally and mostly affect the extremities. DSAPs 
have a wider distribution than the porokeratosis of Mibelli and usually appears between the age of 40 and 
50. Squamous cell carcinoma, Bowen’s disease, and basal cell carcinoma that arises in the classical type of 
porokeratosis of Mibelli is well-documented, but there are not many reported cases of Bowen’s disease and 
basal cell carcinoma arising in DSAP. We present a 77-year-old woman in whom the two– Bowen’s disease 
and Basal cell carcinoma develop in a histologically proven DSAP. 
Keywords: disseminated superficial actinic porokeratosis, squamous cell carcinoma, Bowen’s disease, 
basal cell carcinoma
INTRODUCTION
Porokeratosis is a keratinization abnormality, 
presenting with atrophic patches surrounded by a 
clinically and histologically distinctive hyperkeratot-
ic border called the cornoid lamella. Historically, the 
term porokeratosis was coined on the assumptions 
that cornoid lamellae appear from pores of the sweat 
glands (1). Cornoid lamellation expands peripheral-
ly and forms the raised boundary between normal 
and abnormal keratinocytes, showing disturbed dif-
ferentiation but no increase in the rate of prolifera-
tion (2,3).
Multiple clinical variants of porokeratosis are 
recognized: classic porokeratosis of Mibelli (PM) 
(4); disseminated superficial actinic porokeratosis 
(DSAP) and its non-actinic variant disseminated su-
perficial porokeratosis (DSP); linear porokeratosis; 
porokeratosis palmaris et plantaris disseminata and 
punctate porokeratosis, which is thought to be a vari-
ant of the previous form.
DSAP is the most common subtype of poroker-
atosis (5). This is an autosomal dominant condition 
with a typical lesion - annular, hyperkeratotic, brown 
or brownish macules and papules. The center of the 
lesions is atrophic and the border spreads centrifu-
gally in raised ridges. Lesions almost always affect 
sun-exposed areas (5,6). 
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In the right gluteal region, a solitary, erythema-
tous plaque with a diameter of 10 mm was observed, 
characterized by telangiectasias on the periphery of 
the lesion (Fig. 2).  
Skin biopsy was taken from the left lower ex-
tremity lesion. The gluteal plaque was excised totally 
with 5 mm surgical margins.
Histopathology examination of the specimen 
obtained from the erythematous plaque on the left 
shin showed: clonal island of atypical keratinocytes 
within the epidermis. Glassy, eosinophilic cells. Fo-
cally presented buckshot scatter. Apoptotic keratino-
cytes scattered within nests. Compact and paraker-
atotic overlying stratum corneum. The pathological 
diagnosis was squamous cell carcinoma in situ (SC-
CIS, Bowen’s disease) (Fig. 3).
Malignancies, typically squamous cell carcino-
mas, may develop within lesions of porokeratosis in 
about 7.5% of patients (7,8,9).
CASE REPORT
A 77-year-old female presented to our depart-
ment in 2016 with skin lesions on both lower extrem-
ities. Although the skin findings had long duration, 
in the past two years they increased significantly in 
number. Subjectively, the patient found the lesions 
pruritic. The objective findings were typical for po-
rokeratosis – annular, hyperkeratotic, brownish pap-
ules on both shins. Biopsy was performed and speci-
men was taken from two skin lesions. The diagnos-
tic features of disseminated superficial actinic poro-
keratosis were present: a cornoidlamella - parakera-
totic column overlying a small vertical zone of dys-
keratotic cells within the epidermis and focal loss of 
the  granular layer. After histological confirmation 
of the diagnosis, a systemic treatment with Acitretin 
was initiated – 3 tablets a day for a 3-month period.
On a follow-up visit 4 years later, the patient 
showed good therapeutic result on both of her low-
er extremities. Nevertheless, there were two slowly 
growing lesions – one on the left shin and the other - 
in the right gluteal region.
On physical examination the lesion on the left 
lower extremity presented as solitary, erythematous, 
irregular, scaly, crusted plaque, with irregular bor-
ders and a diameter of 40 mm (Fig. 1).  
Fig. 1. Left lower extremity skin lesion
Fig. 2. Right gluteal skin lesion
Fig.3. Histological findings of lower extremity skin lesion
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Histopathology examination of the lesion from 
the right gluteal region showed: basaloid epithelial 
tumour arising from the epidermis. The basaloid ep-
ithelium formed a palisade with a cleft from the adja-
cent tumor stroma. Centrally, the nuclei were crowd-
ed with scattered mitotic figures and necrotic bod-
ies. Mucinous stroma was seen. The diagnosis of su-
perficial basal cell carcinoma was histologically con-
firmed (Fig. 4). 
As the margins of the specimen were clear, the 
patient was considered cured from the basal cell car-
cinoma. Nevertheless, the next operation for the 
treatment of the SCCIS lesion was planned.
DISCUSSION
DSAP is the most common form of poroker-
atosis, and may account for almost half of all cases 
(10). Porokeratosis most commonly occurs in fair-
skinned individuals. DSAP is twice as likely to de-
velop in women compared to men (11). DSAP affect 
all ages, but occurs mainly in the 3rd and 4th decade. 
Typically, the lesions affect sun-exposed ar-
eas, predominantly upper and lower extremities. Pa-
tients develop a few to several dozen pigmented, an-
nular macules with raised peripheral ridges, devel-
oping predominantly on the distal extensor surfaces 
of the legs and the arms. Palms and soles are spared, 
and facial lesions may be seen in less than 15% of pa-
tients. Hyperkeratotic variants have been described. 
The lesions are usually asymptomatic, but they may 
be itchy or slightly stinging (12). 
The pathogenesis of DSAP is not fully under-
stood, but overexpression of p53 is described (13,14). 
This can be induced by several factors, like UV light, 
gene mutations, DNA damaging agents and others 
(8,15,16). 
Exacerbations have been reported following 
prolonged sun exposure, repeated tanning bed expo-
sure, electron beam radiation therapy, and therapeu-
tic phototherapy or photochemotherapy for psoria-
sis. Drug-induced photosensitivity may play a role. 
Protection from ultraviolet radiation may lead to 
spontaneous resolution. Additionally, immunosup-
pression predisposes patients to both DSAP and DSP.
The differential diagnoses are: actinic kerato-
ses, pityriasis lichenoides chronica, and chronic ecze-
ma. The characteristic histopathology findings usu-
ally confirm the diagnosis. 
The prognosis is generally excellent. The oc-
currence of some types of pre-malignancies or ma-
lignancies proves the pre-cancerous nature of this 
condition. Malignancies have been reported for the 
porokeratosis of Mibelli, linear porokeratosis, po-
rokeratosis palmaris et plantaris, and DSAP. As-
sociated malignancies are BCC, SCC, Bowen’s dis-
ease (8,16,17). There are many case reports of these 
types of malignancy arising from some kind of po-
rokeratosis (13). In most cases neoplasms appear on 
the extremities. That proves the role of UV rays in 
malignant transformation of DSAP lesions (13,18). 
Large lesions of porokeratosis, linear porokeratosis, 
or porokeratosis in an immunocompromised patient 
should be monitored carefully for the development of 
cutaneous malignancies (19).
Patients should be advised to practice strict sun 
protection. The measures include wearing protective 
clothing, applying sunscreens and discontinuing ex-
posure to artificial ultraviolet light. The skin of the 
individuals with DSAP should be periodically exam-
ined for lesions suggestive of malignancy. If familial 
porokeratosis is suspected, family members should 
also be examined for porokeratosis.
Fig. 4. Histological findings of gluteal skin lesion
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Aesthetic results from the treatment of DSAP 
lesions are usually unsatisfactory. Nevertheless, ma-
lignant transformation of skin lesions should be ex-
pected and promptly treated as our case also showed. 
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